Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation

Hiroto Izumi, Rina Kanda, Yuichi Murakami, Yasuo Morimoto, Mayumi Ono
European Respiratory Journal 2014 44: P508; DOI:
Hiroto Izumi
1Department of Occupational Pneumology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rina Kanda
2Department of Pharmaceutical Oncology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuichi Murakami
2Department of Pharmaceutical Oncology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuo Morimoto
1Department of Occupational Pneumology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mayumi Ono
2Department of Pharmaceutical Oncology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 44 no. Suppl 58

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online December 23, 2014.

Copyright & Usage 
© 2014 ERS

Author Information

  1. Hiroto Izumi1,
  2. Rina Kanda2,
  3. Yuichi Murakami2,
  4. Yasuo Morimoto1 and
  5. Mayumi Ono2
  1. 1Department of Occupational Pneumology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
  2. 2Department of Pharmaceutical Oncology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan

Article usage

Article usage: December 2014 to February 2023

AbstractFullPdf
Dec 20141500
Jan 20151700
Feb 20151300
Mar 20151300
Apr 20151700
May 20151600
Jun 20151200
Jul 20152000
Aug 2015900
Sep 20151100
Oct 2015500
Nov 2015300
Dec 2015300
Jan 2016500
Mar 2016500
Apr 2016800
May 2016200
Jun 2016100
Jul 2016200
Aug 20161300
Sep 20161600
Oct 20162000
Nov 2016100
Dec 2016400
Jan 2017400
Feb 2017700
Mar 20171100
Apr 2017500
May 20171100
Jun 20171000
Jul 2017800
Aug 2017700
Sep 20171000
Oct 2017300
Nov 2017900
Dec 2017700
Jan 2018500
Feb 2018400
Mar 2018400
Apr 2018300
May 2018300
Jun 2018800
Jul 2018600
Aug 2018100
Sep 2018500
Oct 2018600
Nov 2018700
Dec 2018200
Jan 2019500
Feb 2019100
Mar 2019500
Apr 2019100
Jun 2019100
Jul 2019400
Aug 2019500
Sep 2019200
Oct 2019500
Nov 2019500
Dec 2019600
Jan 2020400
Feb 2020400
Mar 2020900
Apr 2020800
May 2020500
Jun 2020400
Jul 2020100
Aug 2020201
Sep 2020800
Oct 2020300
Nov 2020400
Dec 2020400
Feb 2021500
Mar 2021300
Apr 2021200
May 2021300
Jun 2021600
Jul 2021300
Aug 20211000
Sep 2021500
Oct 20212900
Nov 20211100
Dec 20211200
Jan 20221700
Feb 2022300
Mar 2022500
Apr 2022200
May 2022200
Jun 2022500
Jul 20221100
Aug 2022300
Sep 2022300
Oct 2022300
Nov 2022300
Dec 2022100
Jan 2023100
Feb 2023200

Altmetrics

Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
Hiroto Izumi, Rina Kanda, Yuichi Murakami, Yasuo Morimoto, Mayumi Ono
European Respiratory Journal Sep 2014, 44 (Suppl 58) P508;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
Hiroto Izumi, Rina Kanda, Yuichi Murakami, Yasuo Morimoto, Mayumi Ono
European Respiratory Journal Sep 2014, 44 (Suppl 58) P508;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
  • Evaluation of response to chemotherapy with fiberoptic bronchoscopy in lung cancers
  • Equal efficacy of gefitinib in chemonaive lung adenocarcinoma patients with either exon 19 deletion or L858R point mutation
Show more 11.1 Lung Cancer

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society